Results 81 to 90 of about 7,281,976 (241)
Pediatric Blood &Cancer, EarlyView.ABSTRACT Background Although significant progress has been made in childhood leukemia survival, healthcare providers, and caregivers often face challenges in explaining this disease to patients. Disease‐targeted storybooks have been proposed as a tool to facilitate the understanding of diagnoses and treatment.
Nutvipha Ummartyotin +6 more
wiley +1 more source
Editorial: Artificial Intelligence and Innovation Management (December 2019)
Technology Innovation Management Review, 2019 Stoyan Tanev, Gregory Sandstrom
doaj +1 more source
Editorial: Insights (January 2020)
Technology Innovation Management Review, 2020 Stoyan Tanev, Gregory Sandstrom
doaj +1 more source
Pediatric Blood &Cancer, EarlyView.ABSTRACT Pediatric supportive care clinical trials often involve multiple clinically important outcomes, complicating trial interpretation. Hierarchical composite endpoints (HCEs) provide a framework to integrate key outcomes according to clinical importance.
Willem H. Collier +11 more
wiley +1 more source
Editorial: Insights (July 2020)
Technology Innovation Management Review, 2020 Stoyan Tanev, Gregory Sandstrom
doaj +1 more source
Journal of South African Botany(Uploaded by Plazi from the Biodiversity Heritage Library) No abstract provided.
openaire +11 more sources
The Role of Chemotherapy in Pediatric Myoepithelial Carcinoma: A Systematic Review of the Literature
Pediatric Blood &Cancer, EarlyView.ABSTRACT Myoepithelial carcinoma (MEC) in pediatric patients is a rare and aggressive malignancy characterized by heterogeneous morphology and variable molecular features. The optimal role of chemotherapy remains unclear. We conducted a systematic review according to PRISMA 2020 guidelines to evaluate chemotherapy in pediatric and young‐adult patients ...
Marco Salvi +7 more
wiley +1 more source
Editorial: Innovating in Times of Crisis (September 2020)
Technology Innovation Management Review, 2020 Stoyan Tanev, Gregory Sandstrom
doaj +1 more source
Determining Parental Factors for Clinical Trial Attrition in Pediatric Acute Lymphoblastic Leukemia
Pediatric Blood &Cancer, EarlyView.ABSTRACT Background/Objectives Despite high enrollment rates on Children's Oncology Group (COG) protocols, attrition after initial consent is challenging, introducing bias and prolonging trial completion. While adult oncology literature has identified predictors of withdrawal, little is known about caregiver decision‐making for child participation in ...
Kimberly L. Stathas +3 more
wiley +1 more source